Mathilde Chevin

Mathilde Chevin
Biospective, Inc. · in vivo studies

Doctor of Philosophy in Neuroscience
Research Scientist, in vivo studies at Biospective Inc

About

18
Publications
1,510
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
153
Citations
Citations since 2017
12 Research Items
148 Citations
20172018201920202021202220230102030
20172018201920202021202220230102030
20172018201920202021202220230102030
20172018201920202021202220230102030
Introduction
Mathilde Chevin currently works as Research Scientist at Biospective Inc. Current projects involve CNS diseases modelization in mice and rats, treatment and characterization by imaging and histology. Mathilde does research in Biochemistry, Neuroscience and Immunology.
Additional affiliations
May 2014 - May 2016
Université de Sherbrooke
Position
  • Master's Student

Publications

Publications (18)
Article
Full-text available
Aim To test the association between perinatal inflammation exposure and Full-Scale IQ (FSIQ) score 7 years after neonatal arterial ischaemic stroke (NAIS). Method We conducted a cross-sectional ancillary study nested in a multicentric longitudinal French cohort of infants born at term with NAIS between November 2003 and October 2006. Seventy-three...
Article
Full-text available
Neonatal encephalopathy (NE) caused by hypoxia-ischemia (HI) affects around 1 per 1000 term newborns and is the leading cause of acquired brain injury and neurodisability. Despite the use of hypothermia (HT) as a standard of care, the incidence of NE and its devastating outcomes remains a major issue. Ongoing research surrounding add-on neuroprotec...
Article
Résumé L'accident vasculaire cérébral (AVC) regroupe six catégories nosologiques qui diffèrent par leurs causes et mécanismes, leur temporalité et mode de présentation clinique et l’évolution. Par définition, l'AVC néonatal – lui-même divisé en infarctus cérébral artériel néonatal, thrombose néonatale des sinus et des veines cérébraux, et hémorragi...
Article
Necroptosis is emerging among possible mechanisms underlying cell death in neurodegenerative diseases. In this line, we hypothesize that necroptosis might be implicated in neuronal cell death in amyotrophic lateral sclerosis (ALS). To support this hypothesis, we hereby provide pilot data as well as some findings from the literature about the expres...
Article
Background: There is currently no targeted treatment available for neonatal arterial ischemic strokes (NAIS). Epidemiological studies demonstrated that perinatal infection/inflammation, peripartum hypoxia, and occlusion of the internal carotid tree are the main determinants of NAIS. The well-established benefit of therapeutic hypothermia (HT) in n...
Article
Full-text available
Introduction Aucun traitement n’est actuellement disponible pour l’infarctus cérébral artériel néonatal (NAIS). Les études épidémiologiques ont montré que l’infection/inflammation périnatale, l’hypoxie perpartum associées à l’occlusion d’une artère cervico-encéphalique sont les principaux déterminants du NAIS. L’effet neuroprotecteur de l’hypotherm...
Article
Full-text available
Background: Hypothermia is increasingly tested in several neurological conditions, such as neonatal encephalopathy, stroke, traumatic brain injury, subarachnoid hemorrhage, spinal cord injury, and neurological outcomes of cardiac arrest. Current studies aim to increase benefits of hypothermia with new add-on therapies including immunomodulatory ag...
Article
Full-text available
Based on the review of the literature, perinatal inflammation often induced by infection is the only consistent independent risk factor of neonatal arterial ischemic stroke (NAIS). Preclinical studies show that acute inflammatory processes take place in placenta, cerebral arterial wall of NAIS-susceptible arteries and neonatal brain. A top research...
Article
Background: Despite the recent introduction of hypothermia as a mandatory standard of care, the incidence of neonatal encephalopathy in full-term newborns and its devastating neuro-behavioral outcomes continues to be a major individual, familial and social issue. Neonatal encephalopathy is mainly due to the compounding and interacting effects of h...
Poster
Full-text available
Poster presented at the International Society for Developmental Neuroscience (ISDN) meeting, May 11-14, 2016.
Chapter
It is known that gestational and/or perinatal inflammation combined or not with hypoxia-ischemia (HI) is a risk factor for brain injuries, but the mechanisms underlying are still unclear. This chapter discusses about animal models mimicking those conditions, allowing scientists to uncover mechanisms involved and to study the adverse effects on the...
Research
Full-text available
Canadian National Perinatal Research Meeting, february 2015. Poster session
Article
Full-text available
Inflammation due to remote pathogen exposure combined to hypoxia/ischemia (HI) is one of the most common causes of neonatal encephalopathy affecting at-term or near-term human newborn, which will consequently develop cerebral palsy. Within term-equivalent rat brains exposed to systemic lipopolysaccharide (LPS) plus HI, it was previously showed that...

Network

Cited By